Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gavras

Showing results (301-310 of 312) with videos related to

Pageof 32
Sort By:
Hypertension (Dallas, Tex. : 1979)|January 1, 1997
Role of substance P in blood pressure regulation in salt-dependent experimental hypertensionO Kohlmann, M L Cesaretti, M Ginoza, et al.
Circulation Research|May 1, 1971
Microangipathic hemolytic anemia and the development of the malignant phase of hypertensionH Gavras, W C Brown, J J Brown, et al.
British Heart Journal|August 1, 1973
Microangiopathic haemolytic anaemia in malignant phase hypertensionN Oliver, H Gavras, J Aitchison, et al.
Kidney & Blood Pressure Research|October 13, 2006
Is 44-hour better than 24-hour ambulatory blood pressure monitoring in hemodialysis?L C Martin, R J S Franco, I Gavras, et al.
Archives of Internal Medicine|December 1, 1989
Dilevalol in severe hypertension. A multicenter trial of bolus intravenous dosingJ D Wallin, M E Cook, E Fletcher, et al.
Kidney International. Supplement|September 1, 1975
Abnormalities of coagulation and the development of malignant phase hypertensionH Gavras, N Oliver, J Aitchison, et al.
Clinical Pharmacology and Therapeutics|May 1, 1981
Three new long-acting converting-enzyme inhibitors: relationship between plasma converting-enzyme activity and response to angiotensin IJ Biollaz, M Burnier, G A Turini, et al.
American Journal of Hypertension|December 21, 2004
Association between hypervolemia and ventricular hypertrophy in hemodialysis patientsL C Martin, R J S Franco, I Gavras, et al.
American Journal of Human Genetics|October 30, 1998
Autosomal dominant orthostatic hypotensive disorder maps to chromosome 18qA L DeStefano, C T Baldwin, M Burzstyn, et al.
Clinical Nephrology|January 1, 1975
Plasma angiotensin II, renin, renin-substrate and aldosterone concentrations in acute renal failure in manA M Paton, A F Lever, N W Oliver, et al.
Pageof 32

Showing results (301-310 of 312) with videos related to

Sort By:
Pageof 32
Hypertension (Dallas, Tex. : 1979)|January 1, 1997
Role of substance P in blood pressure regulation in salt-dependent experimental hypertensionO Kohlmann, M L Cesaretti, M Ginoza, et al.
Circulation Research|May 1, 1971
Microangipathic hemolytic anemia and the development of the malignant phase of hypertensionH Gavras, W C Brown, J J Brown, et al.
British Heart Journal|August 1, 1973
Microangiopathic haemolytic anaemia in malignant phase hypertensionN Oliver, H Gavras, J Aitchison, et al.
Kidney & Blood Pressure Research|October 13, 2006
Is 44-hour better than 24-hour ambulatory blood pressure monitoring in hemodialysis?L C Martin, R J S Franco, I Gavras, et al.
Archives of Internal Medicine|December 1, 1989
Dilevalol in severe hypertension. A multicenter trial of bolus intravenous dosingJ D Wallin, M E Cook, E Fletcher, et al.
Kidney International. Supplement|September 1, 1975
Abnormalities of coagulation and the development of malignant phase hypertensionH Gavras, N Oliver, J Aitchison, et al.
Clinical Pharmacology and Therapeutics|May 1, 1981
Three new long-acting converting-enzyme inhibitors: relationship between plasma converting-enzyme activity and response to angiotensin IJ Biollaz, M Burnier, G A Turini, et al.
American Journal of Hypertension|December 21, 2004
Association between hypervolemia and ventricular hypertrophy in hemodialysis patientsL C Martin, R J S Franco, I Gavras, et al.
American Journal of Human Genetics|October 30, 1998
Autosomal dominant orthostatic hypotensive disorder maps to chromosome 18qA L DeStefano, C T Baldwin, M Burzstyn, et al.
Clinical Nephrology|January 1, 1975
Plasma angiotensin II, renin, renin-substrate and aldosterone concentrations in acute renal failure in manA M Paton, A F Lever, N W Oliver, et al.
Pageof 32